You are here

Treatments

Analysis: Africa's progress and challenges in confronting pandemics--report

Fri, 2022-10-14 23:18 — mike kraft

Africa: Ready to Respond | Think Global Health The changing story of a vulnerable continent better prepared to respond to pandemics Council on Foreign Relations

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Problem, Solution, SitRep, or ?:

Read more about Analysis: Africa's progress and challenges in confronting pandemics--report
Log in or register to post comments

Long Covid: More information sought

Fri, 2022-10-14 16:48 — mike kraft

What you need to know about the latest on long covid U.S. government estimates suggest that between 7 million and 23 million Americans are suffering from the long-term effects of infection with the coronavirus. Frances Stead Sellers Washington Post

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Long Covid: More information sought
Log in or register to post comments

The next U.S. COVID wave will be 'much weirder than before.'

Fri, 2022-10-14 15:53 — mike kraft

The next U.S. COVID wave is coming. Why it will be 'much weirder than before.' It has become pretty much impossible to keep up with all of the latest coronavirus variants, but there's most likely a new wave on the way. YahooNews

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about The next U.S. COVID wave will be 'much weirder than before.'
Log in or register to post comments

Monkeypox treatment trial begins in the Democratic Republic of the Congo

Fri, 2022-10-14 14:55 — mike kraft

Monkeypox treatment trial begins in the Democratic Republic of the NIH partnering with INRB to evaluate tecovirimat (TPOXX). National Institutes of Health (NIH)

...

The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death.

...

Country / Region Tags:

Democratic Republic of the Congo

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Monkeypox treatment trial begins in the Democratic Republic of the Congo
Log in or register to post comments

U.S. Monkeypox response looks to long term strategies

Fri, 2022-10-14 14:28 — mike kraft

Monkeypox response looks to long term - Roll Call Federal officials warn that monkeypox is here to stay, but hope to use a combination of strategies to limit the spread of the virus. Roll Call

Federal officials look to vaccines, treatment, education to limit spread

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. Monkeypox response looks to long term strategies
Log in or register to post comments

What we know about the illness caused by the new Omicron subvariants

Fri, 2022-10-14 14:13 — mike kraft

Omicron symptoms: What we know about illness caused by the new subvariants Symptoms of omicron and the BA.4 and BA.5 subvariants are similar, doctors say. They're all still Covid, and they can still cause severe disease. NBC News

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about What we know about the illness caused by the new Omicron subvariants
Log in or register to post comments

Pfizer, BioNTech's updated booster protects against Omicron in human trial

Thu, 2022-10-13 14:14 — mike kraft

Pfizer, BioNTech's updated booster protects against Omicron in human trial Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants, generated a strong immune response and was well tolerated in testing on humans. Ludwig Burger,Manas Mishra Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer, BioNTech's updated booster protects against Omicron in human trial
Log in or register to post comments

Discussion of what Covid-19 precautions people shoukd take for international travel

Wed, 2022-10-12 23:31 — mike kraft

What Covid-19 precautions should people take for international travel? Last week, the US Centers for Disease Control and Prevention announced it would no longer be maintaining a country-by-country travel advisory of Covid-19 risk. Instead of assessing the level of Covid-19 infection in each country, the CDC will post notices only when there are new variants or other situations that would change its travel recommendations. By Katia Hetter, CNN CNN

..

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Medical Testing

Public Attitudes

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Discussion of what Covid-19 precautions people shoukd take for international travel
Log in or register to post comments

Covid-19 treatment Paxlovid can interact with common heart medications, study cautions

Wed, 2022-10-12 22:19 — mike kraft

Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid -- but there's a catch. Jacqueline Howard CNN

...

Paxlovid can have dangerous interactions with some of the most common medications for cardiovascular disease, including certain statins and heart failure therapies, a new paper warns.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Covid-19 treatment Paxlovid can interact with common heart medications, study cautions
Log in or register to post comments

Novavax says its COVID booster dose shows benefit against Omicron variants

Wed, 2022-10-12 22:08 — mike kraft

Novavax says COVID booster dose shows benefit against Omicron variants Novavax Inc said on Wednesday data from studies in adults and adolescents showed that the booster dose of its COVID vaccine produced robust antibodies against several Omicron variants, including BA.1, BA.2 and BA.5. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax says its COVID booster dose shows benefit against Omicron variants
Log in or register to post comments

Pages

Page loaded in 0.637 seconds.